About Vedanta Biosciences
Vedanta is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious gastrointestinal diseases using defined consortia of bacteria.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Cambridge, United States
Year Founded
2011
Team Size
101-250
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
vedantabio.com
Domain Registered Date
Aug 25, 2010
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $60,000,000 路 Venture Round
fundraisingfox.com
- Capital Raise
Raised $106,500,000 路 Series-B+
- Capital Raise
Series-B+ announced
- Milestone
X account created (@VedantaBio)
1.6K followers
- Milestone
Company founded
Cambridge, United States
- Milestone
Website domain registered
vedantabio.com
Investors & Backers
AMR Action Fund
Atlantic Neptune
AXA Investment Managers
BNP Paribas Asset Management
CARB-X
Colorcon Ventures
Fiscus Ventures
Health for Life Capital fund
JSR
Korea Investment & Securities
Magnetar Capital
Peak 6
Pfizer Venture Investments
PureTech Health
QUAD Investment Management
Reimagined Ventures
Revelation Partners
Rock Springs Capital
Salica
Seventure Partners
Shumway Capital
Skyviews Life Science
SymBiosis
Verition Fund Management
Funding History
Venture Round
· Aug 6, 2026
$60,000,000 fundraisingfox.com
Series-B+
· May 2, 2023
$106,500,000 Source
Series-B+
· Jul 21, 2021
Undisclosed Source
Founders & Leadership
Alexander Rudensky
Founder
Work email & phone locked
Unlock →
Bernat Olle 馃嚭馃嚘
Founder & CEO
Work email & phone locked
Unlock →
Daniel Couto
Chief Operating Officer
Work email & phone locked
Unlock →
David Steinberg
Founder
Work email & phone locked
Unlock →
Jeffrey Silber
CMO
Work email & phone locked
Unlock →
Ruslan Medzhitov
Founder
Work email & phone locked
Unlock →
Silvia Caballero
Director, Infectious Diseases
Work email & phone locked
Unlock →
Simona Levi
Chief Legal Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates 路 Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States 路 Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India 路 Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India 路 Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium 路 Oct 2026